BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy solutions company, is pleased to announce The AscellaHealth Family of Companies, reflecting the company’s ongoing expansion with all partners sharing a mission to put patients first and provide programs, services and end-to-end solutions designed to enhance medication access and optimize clinical outcomes and quality of life for patients with complex chronic conditions or rare diseases. The AscellaHealth Family of Companies includes: strategic partner Optime Care, further enhancing a strong trajectory for overall growth and leading the industry in providing distribution, fulfillment and patient management services for pharmaceutical partners, and Terebellum, a subsidiary of AscellaHealth located in Dublin, Ireland providing group purchasing, financial, payer, market access and market entry services to life sciences manufacturers and other industry stakeholders.
“We are expanding our global footprint to include best-in-class companies that support patient-first, innovative clinical and technology-based solutions designed to improve access to specialty therapies, enhance the overall patient experience and result in optimal outcomes,” says Dea Belazi, president and CEO, AscellaHealth. “This muti-faceted business model includes global payer and market access expertise, and customized HUB and patient support solutions, including a call center composed of experienced Specialty pharmacists and patient coordinators who are knowledgeable about orphan and ultra-orphan diseases.”
AscellaHealth continues to grow its business portfolio globally and ascend its market positioning as a premier partner in SP and healthcare services that puts patients at the center of care. The collective capabilities and robust array of services that these companies provide are not only improving medication access for patients, but also meeting the needs of stakeholders throughout the care continuum, including payers, life sciences and providers.
“AscellaHealth’s consultative, patient-first approach is built upon proprietary technology processes designed to support pharmaceutical manufacturers in product launches and drug management programs,” continues Belazi. “We work diligently to ensure that branded specialty products are brought to the global market successfully and seamlessly accessed by patients via our unique pharmaceutical financial solutions and clinical pull-through programs.”
This approach fosters a high level of brand loyalty and ensures optimal health outcomes, while enabling payers to realize cost savings in specialty spend.
Belazi concludes, “AscellaHealth is truly a family -- a group of companies united by a shared mission to focus on the needs of individuals with specialty conditions and rare diseases who are often struggling to access a diagnosis and ongoing treatment. The ties that bind us rest upon mutual business goals and the ability to complement and interact with each other in the quest for optimal healthcare outcomes.”
To learn more, view AscellaHealth’s corporate video.
About AscellaHealth LLC
AscellaHealth is a global Healthcare & Specialty Pharmacy solutions organization serving patients, payers, life sciences and providers, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and medical management services. An Inc. 5000 2021 winner, AscellaHealth’s unique, patient-centric approach supports its strategic partnership with Optime Care and is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex chronic conditions or rare diseases that require specialty medications and/or gene and cell therapies. Visit www.AscellaHealth.com.
About Optime Care
Optime Care, Inc. is a nationally recognized specialty pharmacy, distribution and patient management organization offering a suite of comprehensive services tailored to maximize the therapeutic opportunities for the treatment of orphan and rare disorders. Our executive team has partnered in the launch and management of over 40 orphan products and programs while consistently implementing the best brand services for the community. Our experience with small patient populations, coupled with our strategic partnership with AscellaHealth, enhances our services and ability to serve the specialty pharmacy market. Optime Care has dual-accreditation from the Utilization Review Accreditation Commission (URAC) for compliance with specialty pharmacy and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy services that demonstrate a commitment to providing quality care and services to consumers. https://www.optimecare.com/
Terebellum is a Dublin, Ireland based subsidiary of AscellaHealth representing our global footprint throughout Europe. Our premier group purchasing services, unique pharmaceutical financial solutions, payer and market access expertise and custom pull-through programs targeted to Life Sciences partners and other industry stakeholders ensure optimal cost savings and enhanced clinical outcomes. Terebellum’s leadership team has the deep payer, reimbursement, marketing and financial expertise needed to provide a consultative approach for branded specialty products to be brought to market successfully.